{"Acquired gene mutation": 33.07876840221489, "Acute graft versus host disease": 11.27876069501697, "Acute hepatic failure": 7.77583781712053, "Acute lymphocytic leukaemia": 6.604668079091947, "Acute myeloid leukaemia": 11.517938374911369, "Acute promyelocytic leukaemia": 22.85371684936645, "Agranulocytosis": 8.878035913894303, "Alveolitis": 87.17841772880637, "Anaemia": 2.42120053817548, "Anti-Muellerian hormone level decreased": 1003.0704904166596, "Aplastic anaemia": 4.956175486850026, "Aspergillus infection": 5.890724589947423, "Atrial fibrillation": 2.465600933031637, "B-cell lymphoma": 13.782308897792818, "B-cell lymphoma recurrent": 86.78978224602395, "Bacteraemia": 10.1551895804153, "Bicytopenia": 23.31936433438412, "Blood follicle stimulating hormone increased": 185.46856782293065, "Blood lactate dehydrogenase increased": 4.7655335060127015, "Blood luteinising hormone increased": 382.81432429938366, "Blood magnesium decreased": 7.547550354952121, "Bone marrow failure": 5.579113675177734, "Brain injury": 2.690599529770381, "Brain oedema": 4.177056157644085, "Bronchopulmonary aspergillosis": 6.8681386893973855, "COVID-19 pneumonia": 2.4565337170204247, "Cardiac failure": 2.427508084502377, "Cardiomyopathy": 7.85212425884016, "Cardiotoxicity": 21.588565504985556, "Central nervous system lymphoma": 27.93473138313545, "Chemotherapy": 24.95755586541064, "Chronic lymphocytic leukaemia recurrent": 49.77560763297469, "Chronic myeloid leukaemia": 5.427430558132807, "Clostridium difficile colitis": 2.1838694768949174, "Clostridium difficile infection": 3.1713530572825075, "Concomitant disease aggravated": 3.822329859486565, "Congenital aplasia": 10.595759792540417, "Cytokine release syndrome": 5.501413541788695, "Cytomegalovirus chorioretinitis": 9.996029640662906, "Cytomegalovirus infection": 2.8757821022014247, "Cytomegalovirus infection reactivation": 8.609450625438626, "Cytopenia": 22.50289046466196, "Diffuse large B-cell lymphoma": 34.81941064044349, "Diffuse large B-cell lymphoma recurrent": 101.48669010949072, "Diffuse large B-cell lymphoma refractory": 94.08617766340936, "Dilated cardiomyopathy": 5.365205940480204, "Disease progression": 10.28520337178969, "Disease recurrence": 2.5475233043321355, "Drug resistance": 2.046394853986681, "Ejection fraction decreased": 5.2485025127004175, "Epstein-Barr virus infection reactivation": 24.616525964638715, "Febrile bone marrow aplasia": 14.738893388231258, "Febrile neutropenia": 33.866760707716715, "Follicular lymphoma": 60.85012272310657, "Gastrointestinal toxicity": 5.511553625063246, "Granulocyte count decreased": 34.600772447016915, "Granulocytopenia": 22.541093690697405, "Haematotoxicity": 7.817870414904575, "Haemoglobin decreased": 2.874994168572329, "Haemophagocytic lymphohistiocytosis": 3.5056478274243608, "Heart rate abnormal": 6.062422331254474, "Hepatic failure": 2.812731149240664, "Hepatic function abnormal": 3.703434639682866, "Hepatitis B": 29.3846056265272, "Hepatitis B reactivation": 44.05824269346044, "Hepatitis fulminant": 3.974093012982332, "Hodgkin's disease": 8.221703260208425, "Hodgkin's disease recurrent": 142.66811151216874, "Hormone level abnormal": 18.69116421200922, "Hydronephrosis": 5.047385593986239, "Hypogammaglobulinaemia": 7.427778595904688, "Hypoxia": 5.066251683724025, "Immune effector cell-associated neurotoxicity syndrome": 11.979266060860573, "Immune-mediated adrenal insufficiency": 10.378304862037805, "Inappropriate antidiuretic hormone secretion": 2.170291675945544, "Infection": 3.125625815851294, "Interstitial lung disease": 7.142306990121552, "Left ventricular dysfunction": 3.170162348835011, "Leukaemia": 3.910483703794333, "Leukopenia": 7.364710802785722, "Lymphadenitis": 3.108217167269122, "Lymphocyte count decreased": 7.865678461439518, "Lymphoma": 2.988285940887218, "Lymphopenia": 4.208275759679525, "Malignant neoplasm progression": 2.241303624174718, "Mucosal inflammation": 6.448123299390503, "Multiple organ dysfunction syndrome": 2.420876958207874, "Myelodysplastic syndrome": 8.745734145159718, "Myelosuppression": 44.27675282111058, "Neoplasm progression": 5.393891934457058, "Neuropathy peripheral": 2.9443194871489795, "Neutropenia": 7.8108823664104, "Neutropenic sepsis": 18.021746827221516, "Neutrophil count decreased": 25.98514192103382, "Neutrophil count increased": 3.476272047505969, "Night sweats": 2.237001474630656, "No adverse event": 2.1329943953204333, "Non-Hodgkin's lymphoma": 6.806077024869822, "Oestradiol decreased": 464.68485732743153, "Off label use": 2.9442877927168305, "Pancytopenia": 7.601580795610622, "Papilloedema": 8.555582261201163, "Platelet count decreased": 6.040020972607379, "Pleural effusion": 2.4776915175397067, "Pneumocystis jirovecii pneumonia": 16.595479193898992, "Pneumonia": 2.906154896568814, "Pneumonia bacterial": 4.575871899759484, "Pneumonitis": 3.712798630356106, "Premature baby": 2.535419214095747, "Premature labour": 4.6279261118858805, "Product use in unapproved indication": 6.81091587579335, "Progressive multifocal leukoencephalopathy": 12.903090360990753, "Pseudomonas infection": 3.812937353762629, "Pulmonary toxicity": 3.965623405448583, "Quadriplegia": 18.82003183202208, "Red blood cell count decreased": 3.606995105170477, "Respiratory failure": 2.0631986957183264, "Richter's syndrome": 109.25620126299856, "Second primary malignancy": 25.89722789329935, "Secondary immunodeficiency": 28.64619921081292, "Sepsis": 5.3972876751242, "Septic shock": 4.488768541598368, "Staphylococcal bacteraemia": 15.23226271758612, "Stomatitis": 2.149192234639877, "Therapy non-responder": 2.0898826184438013, "Therapy partial responder": 8.310131859334078, "Thrombocytopenia": 2.8714863310026666, "Transaminases increased": 2.751072571491272, "Transplant dysfunction": 18.420336878493973, "Tumour lysis syndrome": 15.637144222325285, "Venoocclusive liver disease": 6.068349769367971, "White blood cell count decreased": 18.209014711799416}